Update on Funding & Suspension of Trading
Trellus Health plc has requested a suspension of trading on AIM due to ongoing uncertainty regarding its financial position and limited working capital. While the company has extended its cash runway to mid-June 2026 through cost-saving measures, including compensation reductions and vendor contract renegotiations, it has not yet secured long-term funding. The Board is evaluating all options, including the potential sale of its US subsidiary, Trellus Health Inc., and has engaged corporate restructuring advisers to protect stakeholder interests.
Select text to share a quote on X · sign in to keep highlights & notes in your TRLS notes
Update on Funding
&
Suspension of Trading
Trellus Health plc (AIM: TRLS), a healthcare company delivering Trellus Elevate®, a digital platform that integrates data analytics with personalised, scientifically proven resilience programmes and value-based solutions to manage complex chronic conditions, stated on 13 April 2026 that it had reduced its monthly cash burn to an average of c. $300k as of March 2026 and that, with a contract renewal, and a loan from a co-founder, it expected its cash runway to extend into May 2026.
The Board remains supportive of the Company's commercial strategy and continues to evaluate a range of potential funding options to further extend the Company's cash runway. The Company has further extended its runway until mid-June 2026 through additional cost-saving measures, including further reductions in compensation and the renegotiation of certain vendor contracts amongst other measures.
The Board is, however, mindful that it has not yet been successful in securing long term funding. In addition, although the Convertible Loan Note Facility provided by Alumni Capital LLC remains in place, utilisation continues to be constrained by current market conditions.
Consequently, the Board has engaged corporate restructuring advisers to protect stakeholders' interests, and the Board is now evaluating all options including the sale of Trellus Health Inc., the Company's US subsidiary. Due to the ongoing uncertainty regarding the Company's financial position, its current limited working capital and the circumstances noted above, the Company has requested that its shares are suspended from trading on AIM with effect from 7.30 a.m. today.
Further announcements will be made as appropriate.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.